Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3804)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 14, 2024 (publication date) through Jul 21, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Boldys A, Buldak L. Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration. World J Gastroenterol 2024; 30(18): 2387-2390 [PMID: 38764762 DOI: 10.3748/wjg.v30.i18.2387] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i18/2387.htm |
| Number | Citing Articles |
| 1 |
Anne Brennan. Metabolic Dysfunction-Associated Steatotic Liver Disease: a rapidly growing common liver disease. Gastrointestinal Nursing 2025; 23(Sup6): S11 doi: 10.12968/gasn.2024.0120R3
|
| 2 |
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
|
| 3 |
Ashraf Abbass Basuni, Dina Sweed, Mohammed Fathey Elgazzar, Ashraf Khalil. Exploring serum bile acids as potential noninvasive biomarkers for nonalcoholic fatty liver disease. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00378-9
|
| 4 |
Diana Abu-Halaka, Einat Rauchbach, Haim Zeigerman, Oren Tirosh. DMF, an activator of Nrf2, could mitigate cholic-acid-induced liver damage in high-fat diet. Exploration of Digestive Diseases 2025; 4 doi: 10.37349/edd.2025.100581
|
| 5 |
Sajad Ehtiati, Roya Pakrad, Seyyed Hossein Khatami, Reza Ataei Kachouei, Alireza Doagoo, Hossein Lanjanian, Seyyed Amir Hossein Ghazizadeh Hashemi, Nastaran Hamed, Behzad Hatami, Reyhane Ahmadzade, Farzaneh Salmani, Saeed Karima. Targeting inflammatory dysregulation in metabolic dysfunction-associated steatotic liver disease rat model: the preventive and therapeutic effects of acetyl-11-keto-beta-boswellic acid. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; doi: 10.1007/s00210-025-04340-3
|
| 6 |
Vignesh Rajan, Ambarish Das, J. Venkatachalam, K. K. Lohani, Chandrakant Lahariya. Managing Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Primary Care Settings: A Review. Preventive Medicine: Research & Reviews 2025; 2(4): 183 doi: 10.4103/PMRR.PMRR_159_24
|